Enzymatica Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:EN9 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
15 Nov 24	Buy€4,692	Louise Nicolin	Individual	30,610	€0.15
14 Nov 24	Buy€7,423	Louise Nicolin	Individual	47,543	€0.16
11 Nov 24	Buy€8,078	Louise Nicolin	Individual	50,794	€0.16
07 Nov 24	Buy€3,859	Therese Filmersson	Individual	25,000	€0.15
16 Sep 24	Buy€10,310	Bengt Baron	Individual	45,000	€0.23
29 Apr 24	Sell€17,143	Gudmundur Palmason	Individual	68,300	€0.25
26 Apr 24	Sell€37,950	Gudmundur Palmason	Individual	142,000	€0.27
25 Mar 24	Sell€5,266	Gudmundur Palmason	Individual	19,226	€0.28
23 Feb 24	Sell€80,605	Gudmundur Palmason	Individual	300,000	€0.27

Insider Buying: EN9 insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.4%.

Top 11 shareholders own 21.2% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.9%	Mats Andersson	36,398,195	€5.6m	0%	no data
2.08%	Gudmundur Palmason	4,497,097	€690.8k	-51.7%	no data
1.65%	Bengt Baron	3,552,859	€545.8k	1.28%	no data
0.19%	Therese Filmersson	400,000	€61.4k	6.67%	no data
0.13%	Claus Egstrand	279,453	€42.9k	0%	no data
0.11%	Louise Nicolin	228,947	€35.2k	129%	no data
0.11%	Helene Willberg	228,753	€35.1k	0%	no data
0.039%	Claes Molin	85,023	€13.1k	0%	no data
0.017%	Chris Czyrko	37,000	€5.7k	0%	no data
0.0084%	Elite Fund Management Ltd	18,140	€2.8k	0%	0.03%
0.0068%	FCG Fonder AB	14,765	€2.3k	0%	no data